Benjamin Edwards Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Benjamin Edwards Inc’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.97M	Buy	11,117 +24	+0.2%	+$11.2K	0.05%	333
2025 Q4	$5.03M	Buy	11,093 +597	+6%	+$257K	0.06%	304
2025 Q3	$4.11M	Buy	10,496 +862	+9%	+$360K	0.05%	335
2025 Q2	$4.29M	Buy	9,634 +1,428	+17%	+$658K	0.05%	304
2025 Q1	$3.98M	Buy	8,206 +827	+11%	+$385K	0.06%	295
2024 Q4	$2.97M	Buy	7,379 +711	+11%	+$330K	0.04%	356
2024 Q3	$3.1M	Buy	6,668 +6,535	+4,914%	+$3.14M	0.05%	345
2024 Q2	$62K	Buy	133 +19	+17%	+$8.25K	0.01%	476
2024 Q1	$48K	Buy	+114	New	+$48.2K	0.01%	487
2022 Q2	–	Sell	-17	Closed	-$4K	–	748
2022 Q1	$4K	Buy	17 +9	+113%	+$2.14K	﹤0.01%	664
2021 Q4	$2K	Buy	8 +3	+60%	+$583	﹤0.01%	684
2021 Q3	$1K	Buy	+5	New	+$976	﹤0.01%	532

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Benjamin Edwards Inc's VRTX Position: Q1 2026 in Review

Benjamin Edwards Inc increased its Vertex Pharmaceuticals (VRTX) stake by 0.22% in Q1 2026, buying an estimated $11.2K and bringing the position to 11,117 shares worth $4.97M. The position accounts for 0.05% of the portfolio, ranked #333.

Benjamin Edwards Inc first reported a position in VRTX in Q3 2021 and has held it in 12 quarters since. The position peaked at $5.03M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Benjamin Edwards Inc held 11,117 shares of Vertex Pharmaceuticals worth $4.97M as of Q1 2026.
Benjamin Edwards Inc bought 24 Vertex Pharmaceuticals shares in Q1 2026, an estimated $11.2K.
Vertex Pharmaceuticals made up 0.05% of Benjamin Edwards Inc's portfolio in Q1 2026, its #333 holding.
Benjamin Edwards Inc first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 12 quarters since.
Benjamin Edwards Inc's Vertex Pharmaceuticals position peaked at $5.03M in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Benjamin Edwards Inc's 13F filing for Q1 2026, filed 12 May 2026.